Qingyun Zhang

Title: Qingyun Zhang: Innovator in Cancer Research

Introduction

Qingyun Zhang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of cancer research through his innovative work on human cancer-related genes. With a total of 2 patents, his inventions aim to advance the development of new anti-cancer approaches and medicines.

Latest Patents

Zhang's latest patents focus on the human cancer-related gene LAPTM4B and its encoded products. The inventions disclose various nucleotide sequences that are crucial for understanding cancer mechanisms. These sequences include SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3, SEQ ID No: 6, and SEQ ID No: 8. Additionally, the patents cover polynucleotides that encode specific protein sequences and DNA sequences with over 90% homology to the specified sequences. The implications of these inventions are profound, as they enable the development of new anti-cancer approaches and medicines, potentially creating a significant impact on human society.

Career Highlights

Qingyun Zhang is affiliated with Peking University, where he continues to engage in groundbreaking research. His work has positioned him as a key figure in the scientific community, particularly in the realm of cancer genetics.

Collaborations

Zhang collaborates with notable colleagues, including Rouli Zhou and Genze Shao. These partnerships enhance the research efforts and contribute to the advancement of cancer-related studies.

Conclusion

Qingyun Zhang's innovative contributions to cancer research through his patents on human cancer-related genes highlight his commitment to improving human health. His work not only advances scientific knowledge but also holds the potential to transform cancer treatment.